Australia markets open in 10 hours

Shenzhen Weiguang Biological Products Co., Ltd. (002880.SZ)

Shenzhen - Shenzhen Delayed price. Currency in CNY
Add to watchlist
30.74+0.71 (+2.36%)
At close: 03:04PM CST
Currency in CNY

Valuation measures4

Market cap (intra-day) 6.81B
Enterprise value 7.15B
Trailing P/E 30.99
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)6.39
Price/book (mrq)3.30
Enterprise value/revenue 6.70
Enterprise value/EBITDA 27.14

Trading information

Stock price history

Beta (5Y monthly) 0.12
52-week change 3-2.91%
S&P500 52-week change 322.38%
52-week high 342.18
52-week low 322.05
50-day moving average 328.39
200-day moving average 332.99

Share statistics

Avg vol (3-month) 31.26M
Avg vol (10-day) 31.66M
Shares outstanding 5226.8M
Implied shares outstanding 6231.51M
Float 857.33M
% held by insiders 177.76%
% held by institutions 12.89%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.2
Forward annual dividend yield 40.67%
Trailing annual dividend rate 30.20
Trailing annual dividend yield 30.67%
5-year average dividend yield 40.66
Payout ratio 420.64%
Dividend date 3N/A
Ex-dividend date 431 Oct 2023
Last split factor 21.4:1
Last split date 316 June 2021

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)30 Sept 2023

Profitability

Profit margin 19.75%
Operating margin (ttm)22.35%

Management effectiveness

Return on assets (ttm)5.08%
Return on equity (ttm)10.53%

Income statement

Revenue (ttm)991.93M
Revenue per share (ttm)4.37
Quarterly revenue growth (yoy)54.90%
Gross profit (ttm)N/A
EBITDA 278.88M
Net income avi to common (ttm)195.91M
Diluted EPS (ttm)0.97
Quarterly earnings growth (yoy)94.00%

Balance sheet

Total cash (mrq)192.33M
Total cash per share (mrq)0.85
Total debt (mrq)469.4M
Total debt/equity (mrq)23.78%
Current ratio (mrq)6.42
Book value per share (mrq)8.58

Cash flow statement

Operating cash flow (ttm)278.45M
Levered free cash flow (ttm)-221.56M